Covid-19 vaccines - SAVIMS

COVID-19, Covid-19 vaccines, Reference Library, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 02/03/2023 | COVID-19, Covid-19 vaccines, Reference Library, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Confronting the COVID Vaccine Debate: A Call for Transparency

Director | 01/03/2023 | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Kirsch, S. (2023, March 1). Why is everyone so afraid to talk about the elephant in the room? Steve Kirsch. Substack. https://stevekirsch.substack.com/p/why-is-everyone-so-afraid-to-talk Summary: In his article, Steve Kirsch presents a critical view of the COVID-19 response, arguing that significant errors were made regarding vaccines, masks, social distancing, and lockdowns. He contends that vaccines have

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Cardiovascular Complications from COVID-19 mRNA Vaccines

Director | 24/02/2023 | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Yasmin, F., Najeeb, H., Naeem, U., Moeed, A., Atif, A. R., Asghar, M. S., Nimri, N., Saleem, M., Bandyopadhyay, D., Krittanawong, C., Eljack, M. M. F., Tahir, M. J., & Waqar, F. (2023). Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immunity, Inflammation and Disease, 11, e807.

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Reference Library, Statistical evidence, Vaccines, Viral illnesses

Restricted content

Suzanne | 23/02/2023 | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Reference Library, Statistical evidence, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Effectiveness of the COVID-19 Bivalent Vaccine

Director | 23/02/2023 | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Shrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., & Gordon, S. M. (2022). Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. medRxiv. https://doi.org/10.1101/2022.12.17.22283625 Summary: This study evaluated the effectiveness of the bivalent COVID-19 vaccine among 51,011 employees at the Cleveland Clinic. The results indicated a 30% effectiveness

COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 16/02/2023 | COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 09/02/2023 | COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 02/02/2023 | COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Association of Guillain-Barré Syndrome with COVID-19 Vaccination

Director | 01/02/2023 | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Abara, W. E., Gee, J., Marquez, P., Woo, J., Myers, T. R., DeSantis, A., Baumblatt, J. A. G., Woo, E. J., Thompson, D., Nair, N., Su, J. R., Shimabukuro, T. T., & Shay, D. K. (2023). Reports of Guillain-Barré syndrome after COVID-19 vaccination in the United States. JAMA Network Open, 6(2), e2253845. https://doi.org/10.1001/jamanetworkopen.2022.53845 Summary:

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Estimation of Number Needed to Vaccinate Against COVID-19 Hospitalisation

Director | 25/01/2023 | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: UK Health Security Agency. (2023). Estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group. Retrieved from [URL] Summary: The UK Health Security Agency’s report outlines the calculation of the number needed to